This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and apply the cream. Wash your hands after applying, unless hands are the affected area.
Flucort N Cream is a combination of three medicines: Fluocinolone Topical and Neomycin Topical which treat bacterial skin infections. Fluocinolone Topical is a steroid medicine. It blocks the production of certain chemical messengers (prostaglandins) that make the skin red, swollen and itchy. Neomycin Topical is an antibiotic. It stops bacterial growth by preventing the synthesis of essential proteins required by bacteria to carry out vital functions.
Flucort N Cream may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Flucort N Cream is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby. The baby's skin should not come into direct contact with the treated area of skin. Water-miscible cream/gel is preferred as ointments may expose the baby to harmful effects of Flucort N Cream via licking.
Flucort N Cream may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
There is limited information available on the use of Flucort N Cream in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Flucort N Cream in patients with liver disease. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Flucort N Cream. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 11th Sep 2017.